Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers. - Cunningham PN; Wang Z; Grove ML; Cooper-DeHoff RM; Beitelshees AL; Gong Y; Gums JG; Johnson JA; Turner ST; Boerwinkle E; Chapman AB (PloS one, 2019)